Clinical Trials Logo

Right Ventricular Overload clinical trials

View clinical trials related to Right Ventricular Overload.

Filter by:
  • None
  • Page 1

NCT ID: NCT04459364 Completed - COVID Clinical Trials

The Prevalence of Pulmonary Hypertension in Patients With COVID-19.

Start date: June 1, 2020
Phase:
Study type: Observational [Patient Registry]

The virus infection Covid-19 fills our hospitals and intensive care departments in a very unique way and there is a lack of essential insight into the pathophysiology of the disease. As a result, very specific treatment options are missing. The US Medicines Agency (FDA) has in the last days given a general license for treatment with inhaled nitric oxide (iNO). Inhaled NO in Sweden (and Europe) is approved for the indication of pulmonary hypertension in adults. However, no one has yet described the occurrence of pulmonary hypertension, with or without right ventricular loading, in the Covid-19 patients who become so seriously ill that they need to be treated at an IVA ward. Knowledge of this is, of course, a prerequisite for determining the need for pulmonary artery catheterization (PA catheter, Swan-Ganz catheter) and also to better understand whether iNO treatment or other forms of lung selective vasodilation therapy may be of benefit to this patient group.

NCT ID: NCT01317329 Completed - Obesity Clinical Trials

"Reversibility of Cardiovascular Injury With CPAP Use: Mechanisms Involved"

Start date: March 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the factors that are associated with improved cardiovascular function with the use of CPAP therapy on subjects diagnosed with moderate to severe obstructive sleep apnea.